142 related articles for article (PubMed ID: 36911927)
1. Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.
Ferre R; Elst J; Senthilnathan S; Lagree A; Tabbarah S; Lu FI; Sadeghi-Naini A; Tran WT; Curpen B
Breast Dis; 2023; 42(1):59-66. PubMed ID: 36911927
[TBL] [Abstract][Full Text] [Related]
2. Machine learning for diagnostic ultrasound of triple-negative breast cancer.
Wu T; Sultan LR; Tian J; Cary TW; Sehgal CM
Breast Cancer Res Treat; 2019 Jan; 173(2):365-373. PubMed ID: 30343454
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.
Ma W; Zhao Y; Ji Y; Guo X; Jian X; Liu P; Wu S
Acad Radiol; 2019 Feb; 26(2):196-201. PubMed ID: 29526548
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
5. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
6. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
7. Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.
Sheng W; Xia S; Wang Y; Yan L; Ke S; Mellisa E; Gong F; Zheng Y; Tang T
Front Oncol; 2022; 12():964605. PubMed ID: 36172153
[TBL] [Abstract][Full Text] [Related]
8. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors.
Costantini M; Belli P; Distefano D; Bufi E; Matteo MD; Rinaldi P; Giuliani M; Petrone G; Magno S; Bonomo L
Clin Breast Cancer; 2012 Oct; 12(5):331-9. PubMed ID: 23040001
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.
Boisserie-Lacroix M; Macgrogan G; Debled M; Ferron S; Asad-Syed M; McKelvie-Sebileau P; Mathoulin-Pélissier S; Brouste V; Hurtevent-Labrot G
Oncologist; 2013; 18(7):802-11. PubMed ID: 23821326
[TBL] [Abstract][Full Text] [Related]
11. Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.
Wang Q; Mao N; Liu M; Shi Y; Ma H; Dong J; Zhang X; Duan S; Wang B; Xie H
Clin Imaging; 2021 Apr; 72():136-141. PubMed ID: 33242692
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer molecular subtype classifier that incorporates MRI features.
Sutton EJ; Dashevsky BZ; Oh JH; Veeraraghavan H; Apte AP; Thakur SB; Morris EA; Deasy JO
J Magn Reson Imaging; 2016 Jul; 44(1):122-9. PubMed ID: 26756416
[TBL] [Abstract][Full Text] [Related]
13. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
Agner SC; Rosen MA; Englander S; Tomaszewski JE; Feldman MD; Zhang P; Mies C; Schnall MD; Madabhushi A
Radiology; 2014 Jul; 272(1):91-9. PubMed ID: 24620909
[TBL] [Abstract][Full Text] [Related]
14. Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.
Yan M; Yao J; Zhang X; Xu D; Yang C
Cancer Med; 2024 Feb; 13(3):e6946. PubMed ID: 38234171
[TBL] [Abstract][Full Text] [Related]
15. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
[TBL] [Abstract][Full Text] [Related]
17. Automatic identification of triple negative breast cancer in ultrasonography using a deep convolutional neural network.
Ye H; Hang J; Zhang M; Chen X; Ye X; Chen J; Zhang W; Xu D; Zhang D
Sci Rep; 2021 Oct; 11(1):20474. PubMed ID: 34650065
[TBL] [Abstract][Full Text] [Related]
18. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
Xie T; Zhao Q; Fu C; Bai Q; Zhou X; Li L; Grimm R; Liu L; Gu Y; Peng W
Eur Radiol; 2019 May; 29(5):2535-2544. PubMed ID: 30402704
[TBL] [Abstract][Full Text] [Related]
20. Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms.
Ma M; Liu R; Wen C; Xu W; Xu Z; Wang S; Wu J; Pan D; Zheng B; Qin G; Chen W
Eur Radiol; 2022 Mar; 32(3):1652-1662. PubMed ID: 34647174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
